跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 169 条关于
“Arrivo BioVentures”
全部
169
临床试验
63
药物
10
机构
5
资讯
91
去年
Arrivo BioVentures Repurposes Depression Drug SP-624 Targeting Gender-Specific Gene Expression
11个月前
Asabys Partners Integrates Aliath Bioventures in €468M Strategic Consolidation to Build €1B Life Sciences Platform
去年
FDA Rejects Astellas' Izervay Update; Cytokinetics and Bayer Announce Aficamten Licensing Deal
10个月前
BOOST Pharma Secures €3.1 Million to Advance Stem Cell Therapy for Osteogenesis Imperfecta
去年
Francis Medical Secures $80M Series C Funding for Innovative Water Vapor Ablation Technology
3年前
VarmX Secures €30M Series B2 Funding to Advance Anticoagulation Reversal Drug VMX-C001 Toward Pivotal Trial
去年
Lamassu Biotech Partners with Ohio State University for Dual-Species Acute Pancreatitis Treatment Development
去年
Massalia Therapeutics Launches with Seed Funding to Target Fibrosis-Neoplasm-Neovascularization Interface
去年
Acclaro Medical Secures $23 Million Series B Funding to Advance Revolutionary 2910 nm Fiber Laser Technology for Aesthetic Medicine
去年
PulseSight Therapeutics Advances PST-611 for Dry AMD/Geographic Atrophy into Phase I Trial
第 1 页,共 10 页
上一页
下一页